Zobrazeno 1 - 10
of 817
pro vyhledávání: '"Nagatsu, I"'
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Experimental Gerontology 2001 36(2):283-295
Autor:
Sato, K., Sumi-Ichinose, C., Kaji, R., Ikemoto, K., Nomura, T., Nagatsu, I., Ichinose, Hiroshi, Ito, M., Sako, W., Nagahiro, S., Graybiel, A.M., Goto, S.
Publikováno v:
Proceedings of the National Academy of Sciences. 105:12551-12556
Dopa-responsive dystonia (DRD) is a hereditary dystonia characterized by a childhood onset of fixed dystonic posture with a dramatic and sustained response to relatively low doses of levodopa. DRD is thought to result from striatal dopamine deficienc
Autor:
Ikemoto, K., Suzuki, T., Ichinose, Hiroshi, Ohye, T., Nishimura, A., Nishi, K., Nagatsu, I., Nagatsu, T.
Publikováno v:
Brain Research. 954:237-246
Sepiapterin reductase (SPR) is the enzyme that catalyzes the final step of the synthesis of tetrahydrobiopterin (BH4), the cofactor for phenylalanine hydroxylase, tyrosine hydroxylase (TH), tryptophan hydroxylase, and nitric oxide synthase (NOS). Alt
Autor:
Muramatsu, S.-I., Kume, A., Matsumura, M., Nagatsu, I., Urano, F., Ichinose, Hiroshi, Nagatsu, T., Terao, K., Nakano, I., Ozawa, K., Fujimoto, K.-I., Ikeguchi, K., Shizuma, N., Kawasaki, K., Ono, F., Shen, Y., Wang, L., Mizukami, H.
Publikováno v:
Human Gene Therapy. 13:345-354
One potential strategy for gene therapy of Parkinson's disease (PD) is the local production of dopamine (DA) in the striatum induced by restoring DA-synthesizing enzymes. In addition to tyrosine hydroxylase (TH) and aromatic-L-amino-acid decarboxylas
Autor:
Shen, Y., Nagatsu, I., Urano, F., Suzuki, T., Ichinose, Hiroshi, Nagatsu, T., Monahan, J., Nakano, I., Ozawa, K., Muramatsu, S.-I., Ikeguchi, K., Fujimoto, K.-I., Fan, D.-S., Ogawa, M., Mizukami, H., Urabe, M., Kume, A.
Publikováno v:
Human Gene Therapy. 11:1509-1519
Parkinson's disease (PD), a neurological disease suited to gene therapy, is biochemically characterized by a severe decrease in the dopamine content of the striatum. One current strategy for gene therapy of PD involves local production of dopamine in
Autor:
Fan, D.-S., Ogawa, M., Fujimoto, K.-I., Ikeguchi, K., Ogasawara, Y., Urabe, M., Nishizawa, M., Nakano, I., Yoshida, M., Nagatsu, I., Ichinose, Hiroshi, Nagatsu, T., Kurtzman, G.J., Ozawa, K.
Publikováno v:
Human Gene Therapy. 9:2527-2535
Parkinson's disease (PD) is characterized by the progressive loss of the dopaminergic neurons in the substantia nigra and a severe decrease in dopamine in the striatum. A promising approach to the gene therapy of PD is intrastriatal expression of enz
Autor:
Sumi-Ichinose, C., Hasegawa, S., Ichinose, Hiroshi, Sawada, H., Kobayashi, K., Sakai, M., Fujii, T., Nomura, H., Nomura, T., Nagatsu, I., Hagino, Y., Fujita, K., Nagatsu, T.
Publikováno v:
Journal of Neurochemistry. 64(No. 2):514-524
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996). 106(7-8)
Guanosine triphosphate (GTP) cyclohydrolase I (GCH) is the first and rate-limiting enzyme for biosynthesis of tetrahydrobiopterin, the cofactor of tyrosine hydroxylase (TH). Our previous study reported the presence of GCH in several neuronal groups i
Autor:
Nagatsu, I 1, Kitahama, K 2
Publikováno v:
In Japanese Journal of Pharmacology 1999 79 Supplement 1:32-32